Milder multiple sclerosis course in patients with concomitant inflammatory bowel disease. - Université Pierre et Marie Curie Accéder directement au contenu
Article Dans Une Revue Multiple Sclerosis Journal Année : 2013

Milder multiple sclerosis course in patients with concomitant inflammatory bowel disease.

Résumé

: An association between multiple sclerosis (MS) and inflammatory bowel disease (IBD) has been suggested. The purpose of this study was to compare the disease course of patients with both MS and IBD with that of patients with isolated MS or isolated IBD. Sixty-six MS-IBD patients were identified and were matched with 251 isolated MS and 257 isolated IBD controls. Main outcomes were scores using the Expanded Disability Status Scale (EDSS) in MS and extent of disease extension in IBD at last clinical evaluation. After a median 12 years of disease duration, the median EDSS and the percentages of patients reaching an EDSS of 3.0 and 4.0 were significantly lower in MS-IBD patients than in controls. MS had no impact on IBD. MS course appears to be milder in patients with concomitant IBD.

Domaines

Chimie organique
Fichier non déposé

Dates et versions

hal-00917585 , version 1 (12-12-2013)

Identifiants

Citer

Hélène Zéphir, Corinne Gower-Rousseau, Julia Salleron, Olivier Simon, Marc Debouverie, et al.. Milder multiple sclerosis course in patients with concomitant inflammatory bowel disease.. Multiple Sclerosis Journal, 2013, 20 (8), pp.1135-1139. ⟨10.1177/1352458513515081⟩. ⟨hal-00917585⟩
140 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More